Section one: Contracting authority/entity
one.1) Name and addresses
Leeds Teaching Hospitals NHS Trust (on behalf of The Collaborative-see below)
Supplies Dept, St James Hospial, Trust HQ, Beckett St
Leeds
LS9 7TF
Contact
Mr John Smith
Telephone
+44 1132060413
Country
United Kingdom
NUTS code
UK - United Kingdom
Internet address(es)
Main address
http://www.leedsteachinghospitals.com/
Buyer's address
http://www.leedsteachinghospitals.com/
one.1) Name and addresses
Mid Yorkshire Hospitals NHS Trust
Wakefield
Country
United Kingdom
NUTS code
UK - United Kingdom
Internet address(es)
Main address
one.1) Name and addresses
Calderdale and Huddersfield NHS Foundation Trust
Huddersfield
Country
United Kingdom
NUTS code
UK - United Kingdom
Internet address(es)
Main address
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Collaborative Pathology Managed Service Contract on behalf of Calderdale and
Reference number
DN501953
two.1.2) Main CPV code
- 85111800 - Pathology services
two.1.3) Type of contract
Services
two.1.4) Short description
Calderdale and Huddersfield NHS Foundation Trust (CHFT), Leeds Teaching Hospitals NHS Trust (LTHT) and The Mid Yorkshire Hospitals NHS Trust (MYHT) (The “Collaborative”) are undertaking a competitive dialogue procurement exercise to select a managed service provider to supply The Collaborative’s Pan Pathology Managed Service (lot 1) and Cellular Pathology (lot 2). The provider for lot 2 may be the same provider or a different provider.
The procurement exercise is intended to result in a managed service which provides a flexible, quality and patient focused innovative service in line with best practice ensuring The Collaborative meets the needs of its patients.
The Collaborative wants to partner with a managed service provider to:
• underpin the ambition of The Collaborative as an exemplar Pathology Service now and in the future
• keep pace and evolve with the rapidly changing dynamics of delivering Pathology Services
The procurement exercise is intended to find a provider who will:
• Provide a state-of-the-art solution which can support the requirements today and in the future ensuring there is flexibility to adopt innovative solutions during the term of the contract;
• Provide a solution that meets the quality and speed of testing required by our patients and clinicians and which meets local and national turnaround times;
• Deploy and expand Point of Care testing in hospitals and primary care and self-testing at home;
• Facilitate cross site working and consistent processes to allow flexibility across The Collaborative;
• Support the transformational plans across the trusts, offering the flexibility of solution to support any consolidation of testing between laboratories;
• Work with a provider of Cellular pathology (lot 2) (which may be the same provider or a different provider).
The intended outcome of the procurement exercise is to contract with a provider who agrees to the contract evolving during its life. This will require on-going assessment, implementation of innovative changes and collaborative working with the provider and potential sub-contractors over the life of the contract. The way the service looks at the end of the contract will likely be very different to the initial implementation. Further details as to the contract structure for lot 1 and 2, as well as potential future services are set out in the Descriptive Document.
Section seven. Changes
seven.1.2) Text to be corrected in the original notice
Section number
IV.2.2
Instead of
Date
20 October 2021
Local time
12:00pm
Read
Date
22 October 2021
Local time
12:00pm